Fritextsökning
Innehållstyper
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
KI-rektorn kliver in i Läkemedelsverkets styrelse
Karolinska institutets rektor Annika Östman Wernerson har av regeringen utsetts till ledamot i Läkemedelsverkets styrelse.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Apotek tvingas stänga efter "allvarliga brister" vid inspektion
Läkemedelsverket har beslutat om stängning av ett apotek i Haninge utanför Stockholm till följd av "allvarliga brister".
-
Gasdensitetsmätare med givare
WIKA:s instrument för mätning av gasdensitet ger tillförlitliga varningar för farligt låga gasnivåer, även under under extrema omgivningsförhållanden. Elektrisk...
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Uppmanar till CE-märkning av appar
Läkemedelsverket uppmanar tillverkare av medicinska appar att CE-märka sina produkter.
-
Oväntat stort mörkertal för TBE-infektioner – ”Vi blev väldigt överraskade”
En ny studie tyder på att infektioner av det fästingburna TBE-viruset är långt vanligare i Sverige än man hittills trott.
-
Framåt för kombinationer mot hepatit C
Medivir går in i fas II samtidigt som konkurrenten Gileads kombinationsbehandling mot hepatit C får godkänt av FDA.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Diamyd får snabbspår i USA – ”Oerhört glada”
Svenska Diamyd Medical har beviljats ”Fast Track Designation” – ett snabbspår – av amerikanska FDA för sin immunoterapi under utveckling för patienter med typ 1-diabetes.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Dignitana får EU-pengar till prövning
Stor EU-finansierad studie ska utvärdera mild nedkylning som en ny behandling mot stroke.
-
Lanserar verktyg för analys av svensk forskning
Vetenskapsrådet lanserar Forskningsbarometern, ett verktyg där Sverige som forskningsnation jämförs med andra länder.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.